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ASIT MEDAL 0127 WINNER OF ASIT MEDAL PRIZE: FREE TISSUE
TRANSFER OF A TRANSDUCED FLAP AS A VEHICLE FOR GENE AND
VIRUS THERAPY OF CANCER
Rohit Seth 1, Aadil Khan 1, Tim Pencavel 1, Kevin Harrington 1, Paul
Harris 2. 1 Institute of Cancer Research, London, UK; 2Royal Marsden
Hospital, London, UK
Introduction: Free ﬂap is an integral part of the surgical management of
cancer, but serves no direct function in treating the malignant disease.
However, theﬁeld of gene therapy has opened up the possibility of genetically
modifying freeﬂapswhile theyare detached from thepatient (ex vivo period).
Aim: To establish a working tumour model, in Fischer 344 adult male rats,
assessing the ability to treat microscopic residual disease [MRD], following
cancer resection.
Materials and Methods: The Superﬁcial Inferior Epigastric Artery (SIEA)
was used in Fischer 344 Adult male rats. A reliable tumour cell line (rat
glioma) was established in an isolated vascular territory [IVT]) and also to
mimic MRD. Adenovirus encoding a thymidine kinase gene was trans-
duced into the ﬂap and Ganciclovir (50 mg/ml) was given systemically.
Therapeutic efﬁcacy was determined by the level of tumour growth/
regression that occurred.
Results: This study demonstrated a signiﬁcant delay in tumour growth,
within the IVT (p¼0.004) and in MRD model (p¼0.0005); a signiﬁcant
increase in survival (p¼0.0010) and a signiﬁcant difference in time to reach
measurable tumour growth (p ¼ 0.0001).
Conclusion: Free ﬂaps can be used as vehicles to transmit gene therapy
onto a resected tumour bed, thereby treating MRD.
ASIT MEDAL 0279: MATRIX METALLOPROTEINASE 9 (MMP-9)
PROMOTES TUMOUR PROGRESSION AND METASTASIS IN PATIENTS
WITH COLORECTAL CANCER - A POTENTIAL NOVEL THERAPEUTIC
TARGET?
Arfon Powell, Lindsay Bennett, Clare Orange, Paul Horgan, Joanne
Edwards. University of Glasgow, Glasgow, UK
Introduction: MMP-9 degrades connective tissue and is possibly
responsible for colorectal cancer progression and metastasis. This studyexamines the relationship betweenMMP-9 expression, clinicopathological
factors and survival.
Methods: Immunohistochemical analysis of MMP-9 expression was per-
formed on a tissue microarray (TMA) of parafﬁn embedded tissue from 237
patients undergoing potentially curative resection. Clinicopathological
data including components of the Peterson index (PI) and Klintrup score
was available for analysis.
Results: High MMP-9 expression correlated with higher lymph node ratio
(LNR) (P¼0.015), vascular invasion (P<0.001) and higher PI (P¼0.015).
Minimum follow-up was 46 months; with 70 cancer deaths. On univariate
survival analysis MMP-9 (P<0.001), higher T stage (P¼0.004), higher LNR
(P¼0.004), vascular invasion (P<0.001), higher PI (P<0.001) and low
Klintrup score (P<0.001) was associated with poor survival. On Cox
multivariate analysis, high MMP-9 (Hazard Ratio 3.80 (95%CI 2.03-
7.13);P<0.001), higher PI (HR 2.79 (95%CI 1.58-4.91);P<0.001) and low
Klintrup score (HR 3.49 (95%CI 1.65-7.40);P<0.001) were independently
associated with cancer-speciﬁc survival. High MMP-9 expression retained
prognostic signiﬁcance (P<0.001) in node negative patients.
Conclusions: MMP-9 plays an important role in colorectal cancer
progression and metastasis. The mechanisms underlying MMP-9 expres-
sion may offer a novel therapeutic target for patients at risk of recurrence.
ASIT MEDAL 0326: IMAGING ASSESSMENT OF DESMOID TUMOURS IN
FAMILIAL ADENOMATOUS POLYPOSIS: IS STATE OF THE ART 1.5T MRI
BETTER THAN 64-MDCT?
Santosh Bhandari 1, Ashish Sinha 1, Anika Hansmann 1, Arun Gupta 1, David
Burling 1, Robin Phillips 1, Susan Clark 1, Vicky Goh 2. 1 St Mark's Hospital,
Harrow, Middlesex, UK; 2Mount Vernon Hospital, Northwood, Middlesex, UK
Aim: Desmoid tumour is a common extra intestinal manifestation of
patients with familial adenomatous polyposis (FAP). We aimed to deter-
mine whether MRI provides equivalent or better assessment of desmoids
than CT, the current ﬁrst-line investigation.
Patients and Methods: Following ethical approval and informed consent,
FAP patients with known desmoid underwent contrast enhanced 64-
MDCT and 1.5T-MRI. The number, site, size, local extent, tumour signal
intensity and desmoid to aorta enhancement ratio (ER) were analysed.
